401 related articles for article (PubMed ID: 16891215)
1. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance.
Zhang L; Yi H; Xia XP; Zhao Y
Autoimmunity; 2006 Jun; 39(4):269-76. PubMed ID: 16891215
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta and all-trans retinoic acid generate ex vivo transgenic regulatory T cells with intestinal homing receptors.
Moore C; Sauma D; Morales J; Bono MR; Rosemblatt M; Fierro JA
Transplant Proc; 2009; 41(6):2670-2. PubMed ID: 19715998
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
[TBL] [Abstract][Full Text] [Related]
4. De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid.
Wang J; Huizinga TW; Toes RE
J Immunol; 2009 Sep; 183(6):4119-26. PubMed ID: 19717521
[TBL] [Abstract][Full Text] [Related]
5. Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells.
Huber S; Stahl FR; Schrader J; Lüth S; Presser K; Carambia A; Flavell RA; Werner S; Blessing M; Herkel J; Schramm C
J Immunol; 2009 Apr; 182(8):4633-40. PubMed ID: 19342638
[TBL] [Abstract][Full Text] [Related]
6. The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road.
Zhang L; Zhao Y
J Cell Physiol; 2007 Jun; 211(3):590-7. PubMed ID: 17311282
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
8. Defective functions of circulating CD4+CD25+ and CD4+CD25- T cells in patients with chronic ordinary urticaria.
Chen WC; Chiang BL; Liu HE; Leu SJ; Lee YL
J Dermatol Sci; 2008 Aug; 51(2):121-30. PubMed ID: 18440785
[TBL] [Abstract][Full Text] [Related]
9. The phenotypic characterization of naturally occurring regulatory CD4+CD25+ T cells.
Yi H; Zhen Y; Jiang L; Zheng J; Zhao Y
Cell Mol Immunol; 2006 Jun; 3(3):189-95. PubMed ID: 16893499
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells.
Wahl SM; Swisher J; McCartney-Francis N; Chen W
J Leukoc Biol; 2004 Jul; 76(1):15-24. PubMed ID: 14966194
[TBL] [Abstract][Full Text] [Related]
11. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE.
Liu Y; Teige I; Birnir B; Issazadeh-Navikas S
Nat Med; 2006 May; 12(5):518-25. PubMed ID: 16633347
[TBL] [Abstract][Full Text] [Related]
12. Foxp3-transduced polyclonal regulatory T cells suppress NK cell functions in a TGF-beta dependent manner.
Zhou H; Chen L; You Y; Zou L; Zou P
Autoimmunity; 2010 Jun; 43(4):299-307. PubMed ID: 20166879
[TBL] [Abstract][Full Text] [Related]
13. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other.
Horwitz DA; Zheng SG; Gray JD
Trends Immunol; 2008 Sep; 29(9):429-35. PubMed ID: 18676178
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
Kosiewicz MM; Alard P; Liang S; Clark SL
Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function.
Tang Q; Boden EK; Henriksen KJ; Bour-Jordan H; Bi M; Bluestone JA
Eur J Immunol; 2004 Nov; 34(11):2996-3005. PubMed ID: 15468055
[TBL] [Abstract][Full Text] [Related]
17. VEGFR2 is selectively expressed by FOXP3high CD4+ Treg.
Suzuki H; Onishi H; Wada J; Yamasaki A; Tanaka H; Nakano K; Morisaki T; Katano M
Eur J Immunol; 2010 Jan; 40(1):197-203. PubMed ID: 19902430
[TBL] [Abstract][Full Text] [Related]
18. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells.
Fantini MC; Rizzo A; Fina D; Caruso R; Becker C; Neurath MF; Macdonald TT; Pallone F; Monteleone G
Eur J Immunol; 2007 Nov; 37(11):3155-63. PubMed ID: 17918200
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of foxp3+ T regulatory cell-mediated suppression.
Shevach EM
Immunity; 2009 May; 30(5):636-45. PubMed ID: 19464986
[TBL] [Abstract][Full Text] [Related]
20. Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg.
Horwitz DA; Zheng SG; Wang J; Gray JD
Eur J Immunol; 2008 Apr; 38(4):912-5. PubMed ID: 18395858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
